Abstract:Background: Neural Precursor Cell Expressed Developmentally Down-Regulated Protein 1 (NEDD1) serves as a crucial factor in promoting cellular mitosis by directly facilitating wheel assembly and daughter centriole biogenesis at the lateral site of parent centrioles, ultimately driving centrosome replication. The amplification of centrosomes and the abnormal expression of centrosome-associated proteins contribute to the invasion and metastasis of non-small cell lung cancer cells. However, the specific mechanism by which NEDD1 contributes to the progression of lung adenocarcinoma (LUAD) remains unexplored. Therefore, the objective of this study is to uncover the role played by NEDD1 in LUAD. Methods: To verify the expression of NEDD1 in pan-carcinoma. The feasibility of NEDD1 as a prognostic marker for LUAD in TCGA and GEO databases was verified. Subsequently, Cox proportional hazard regression analysis was used to screen the prognostic factors of LUAD, so as to analyze the correlation between prognostic factors and NEDD1 expression. For another, NEDD1-related genes were screened for pathway enrichment analysis to verify their possible functions. In addition, the expression of NEDD1 in LUAD was verified by qPCR and IHC, then siRNA was used to construct NEDD1-knocked lung cancer cells for subsequent cytobehavioral experiments. Finally, the distribution of NEDD1 in single-cell samples was revealed, and then the correlation between its overexpression and LUAD immune escape and drug resistance was analyzed. Results: LUAD exhibits upregulation of NEDD1, which in turn promotes the proliferation, migration, invasion, and epithelial-mesenchymal transition of lung cancer cells, thereby contributing to a poor prognosis. Furthermore, the overexpression of NEDD1 is closely associated with immune escape and drug resistance in LUAD. Conclusion: NEDD1 serves as a reliable prognostic marker for LUAD, and its upregulation is associated with increased immune escape and drug resistance. Given these findings, NEDD1 holds potential as a novel therapeutic target for the treatment of LUAD.

Supplementary Figures 1-12 from the CRTC1-NEDD9 Signaling Axis Mediates Lung Cancer Progression Caused by LKB1 Loss

Data from The CRTC1-NEDD9 Signaling Axis Mediates Lung Cancer Progression Caused by <i>LKB1</i> Loss

The Crtc1-Nedd9 Signaling Axis Mediates Lung Cancer Progression Caused By Lkb1 Loss

Supplementary Table 1 from The CRTC1-NEDD9 Signaling Axis Mediates Lung Cancer Progression Caused by <i>LKB1</i> Loss

Overexpression of NEDD9 is Associated with Altered Expression of E-Cadherin, Β-Catenin and N-Cadherin and Predictive of Poor Prognosis in Non-Small Cell Lung Cancer.

Nedd9 Promotes Lung Cancer Metastasis Through Epithelial- Mesenchymal Transition

Down-regulated NEDD4L facilitates tumor progression through activating Notch signaling in lung adenocarcinoma

Downregulation of NEDD4L by EGFR signaling promotes the development of lung adenocarcinoma

Dependency of human and murine LKB1-inactivated lung cancer on aberrant CRTC-CREB activation

Supplementary Methods from the CRTC1-NEDD9 Signaling Axis Mediates Lung Cancer Progression Caused by LKB1 Loss

NEDD1 Promotes the Development of Lung Adenocarcinoma and Can be Used as a Prognostic Marker

NEDD9 is a Positive Regulator of Epithelial-Mesenchymal Transition and Promotes Invasion in Aggressive Breast Cancer

Long Non-Coding RNA BC087858 Induces Non-T790m Mutation Acquired Resistance to EGFR-TKIs by Activating PI3K/AKT and MEK/ERK Pathways and EMT in Non-Small-cell Lung Cancer

Dependency of LKB1-inactivated lung cancer on aberrant CRTC-CREB activation

Overactivated neddylation pathway as a therapeutic target in lung cancer

NEDD9 may regulate hepatocellular carcinoma cell metastasis by promoting epithelial-mesenchymal-transition and stemness via repressing Smad7

Identification of NLE1/CDK1 Axis As Key Regulator in the Development and Progression of Non-Small Cell Lung Cancer

NEDD1 overexpression increases cell proliferation, tumor immune escape, and drug resistance in LUAD

Camp/creb-Regulated LINC00473 Marks LKB1-inactivated Lung Cancer and Mediates Tumor Growth

NEDD9 Promotes Cancer Stemness by Recruiting Myeloidderived Suppressor Cells Via CXCL8 in Esophageal Squamous Cell Carcinoma

Overexpressed NEDD8 as a potential therapeutic target in esophageal squamous cell carcinoma